Endoron Medical

Catheter-based Endovascular Suturing Device for Abdominal Aortic Aneurysms

Health Tech & Life Sciences
Active
Series A Kefar Sava Founded 2019
Total raised
$15.0M
Last: Series A 2024-07
Stage
Series A
Founded
2019
Headcount
19
HQ
Kefar Sava
Sector
Health Tech & Life Sciences

About

Endoron Medical strives to provide abdominal aortic aneurysm patients undergoing endovascular aneurysm repair with a long-lasting sealing and fixation solution for their endograft.

Aortoseal was developed to mimic the reliable hand-sewn suturing technique from open surgery, evenly distributing staples around the circumference of the aorta and creating leak and migration-free anastomosis. Aortoseal's device holds the stent graft securely in place. It uses a smart stapling mechanism that enables multiple staples to simultaneously penetrate the stent graft and aortic wall. The end result is a suturing effect similar to one performed manually during open surgery that permanently isolates the aneurysm. With a small profile delivery system, Aortoseal is quickly deployed via a single release action.

The company's technology enables the implementation of endograft procedures in almost all types of anatomies and can dramatically reduce complications and reinterventions.

Funding history · 2 rounds · $15.0M total

2024-07
Series A $10.0M
2021-12
Seed $5.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-devicescardiovascularsurgeonssurgeryhospitalsmedical-technologies